Search
Feed aggregator
Merck Launches Phase III Study for KRAS Hopeful, Eyes Challenge to Amgen and BMS
Merck Launches Phase III Study for KRAS Hopeful, Eyes Challenge to Amgen and BMS 4/5/2024
FTC Will Have More Time to Review Novo’s $16.5B Catalent Buy
FTC Will Have More Time to Review Novo’s $16.5B Catalent Buy 4/5/2024
Boehringer Ingelheim Cuts Staff Due to Low Humira Biosimilar Sales: Reuters
Boehringer Ingelheim Cuts Staff Due to Low Humira Biosimilar Sales: Reuters 4/5/2024
Novartis to File for Pluvicto Label Expansion After Promising Phase III Data
Novartis to File for Pluvicto Label Expansion After Promising Phase III Data 4/5/2024
Pfizer Secures FDA Approval for Hemophilia B Gene Therapy, Launches Warranty
Pfizer Secures FDA Approval for Hemophilia B Gene Therapy, Launches Warranty 4/26/2024
Gilead Touts 5% Revenue Jump, Positions for 2024 Growth and Culls Pipeline
Gilead Touts 5% Revenue Jump, Positions for 2024 Growth and Culls Pipeline 4/26/2024
GSK Sues Pfizer and BioNTech Over Alleged COVID-19 Patent Infringement
GSK Sues Pfizer and BioNTech Over Alleged COVID-19 Patent Infringement 4/26/2024
Cigna’s Evernorth to Offer Humira Biosimilar with No Out-of-Pocket Cost
Cigna’s Evernorth to Offer Humira Biosimilar with No Out-of-Pocket Cost 4/26/2024
BMS Decision to Lay Off 2,200 Employees Comes After M&A Spending Spree
BMS Decision to Lay Off 2,200 Employees Comes After M&A Spending Spree 4/26/2024
Tessera Cuts Dozens of Jobs Following Positive Preclinical Results
Tessera Cuts Dozens of Jobs Following Positive Preclinical Results 4/26/2024
FDA Approves Pfizer’s First Gene Therapy, for Hemophilia B
FDA Approves Pfizer’s First Gene Therapy, for Hemophilia B 4/26/2024
BMS to Cut 2,200 Jobs in $1.5B Restructuring as Opdivo Sales Drop in Q1
BMS to Cut 2,200 Jobs in $1.5B Restructuring as Opdivo Sales Drop in Q1 4/25/2024
Merck Gets Q1 Beat as Sales of Cancer Blockbuster Keytruda Jump 20%
Merck Gets Q1 Beat as Sales of Cancer Blockbuster Keytruda Jump 20% 4/25/2024
Sanders Launches Probe of ‘Outrageously High Prices’ of Novo’s Ozempic, Wegovy
Sanders Launches Probe of ‘Outrageously High Prices’ of Novo’s Ozempic, Wegovy 4/25/2024
Regeneron Pays Mammoth $100M to Access CRISPR Enzymes for AAV Delivery
Regeneron Pays Mammoth $100M to Access CRISPR Enzymes for AAV Delivery 4/25/2024
Sanofi and AstraZeneca Scrap Several Early-Stage Programs in Q1
Sanofi and AstraZeneca Scrap Several Early-Stage Programs in Q1 4/25/2024
FTC’s Noncompete Ban Makes Switching Biopharma Jobs Easier
FTC’s Noncompete Ban Makes Switching Biopharma Jobs Easier 4/25/2024
FDA Approves UTILITY’s New Antibiotic for Uncomplicated UTI in Women
FDA Approves UTILITY’s New Antibiotic for Uncomplicated UTI in Women 4/25/2024
7 Types of Difficult Bosses and How to Deal With Them
7 Types of Difficult Bosses and How to Deal With Them 4/25/2024
Why Biopharma Companies Avoid Hiring People Who Need Visas
Why Biopharma Companies Avoid Hiring People Who Need Visas 4/25/2024
World Pharma News
- Optimal timing maximises Paxlovid benefits for treating COVID-19
- European Commission approves Pfizer's EMBLAVEO® for patients with multidrug-resistant infections and limited treatment options
- Researchers develop a new way to safely boost immune cells to fight cancer
- How the Birmingham Drug Discovery Hub created an investment-ready 'drug library'
- Common HIV treatments may aid Alzheimer's disease patients